Pulmonary Fibrosis study: 68Ga-FAPI vs 18F-FDG
Official title Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT
ClinicalTrials.gov ID: NCT05121779
What this study is testing
What is 68Ga-FAPI?
68Ga-FAPI is an investigational medicine, given as an IV infusion (through a vein), being studied as a potential treatment for pulmonary fibrosis.
Also referred to as 68Ga-fibroblast activating protein inhibitors.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study will compare how well the new 68Ga‑FAPI PET/CT scan detects pulmonary fibrosis and tracks treatment response versus the standard 18F‑FDG PET/CT scan.
- Who it's for
- Adults who have been diagnosed with pulmonary fibrosis.
- What's involved
- Participants will receive two PET/CT imaging sessions, one with the 68Ga‑FAPI tracer and one with the standard FDG tracer, and will have related safety checks and questionnaires.
- Time commitment
- The study involves a few visits over a short period, typically completed within a few weeks.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- suspected or confirmed pulmonary fibrosis patients;
- signed written consent.
You likely can't join if
- pregnancy;
- breastfeeding;
- known allergy against FAPI
- any medical condition that in the opinion of the investigator may significantly interfere with study compliance
The study team makes the final eligibility decision.
Where it is enrolling
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Beijing, Beijing Municipality, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.